Globus Medical (GMED) Tops Q2 EPS by 4c, beats revenue

Globus Medical (NYSE: GMED) reported Q2 EPS of $0.63, $0.04 better than the analyst estimate of $0.59. Revenue for the quarter came in at $291.62 million versus the consensus estimate of $279.53 million.

For earnings history and earnings-related data on Globus Medical (GMED) click here.

You May Also Be Interested In

• EU proposes to curb Airbnb and short-term rentals amid housing shortage
• UBS Reiterates Buy Rating on PVH Corp (PVH) on Strong Earnings Growth Potential
• TSX movers: VersaBank jumps 10% as corporate catalysts lift top gainers